The other speakers in Elena’s session, which took place on Wednesday, were Jürgen Knoblich from Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and Jens Puschlof from Utrecht’s Hubrecht Institute. They discussed the recent development of organoid culture models for drug testing, modelling tumour, disease and infection, toxicity screening, personalised and regenerative medicine and organ replacement, and the limitations and challenges that still need to be overcome.
ESOF, which comprises more than conferences, workshops and scientific sessions including more than 200 events open to the general public, takes place every two years in a different European city and attracts delegates from more than 80 countries, including 400 journalists and science communicators, and is attended by about 35,000 people.
Last week CORDIS, the EC’s Community Research and Development Information Service (@CORDIS_EU) published an article on COMIET as part of its latest ‘Results Pack’ on the subject of organoids.
